GNTXGentex Corporation

Consumer Cyclical

$21.04-26% 1Y

$21.04

$20.5852 weeks$28.47

Price

-26%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, no red flags, undemanding price, growing in the filings, the market undecided.

RyuScore 84 of 100: see how it is built

What they do

In November 2024, the Company acquired GalvanEyes, LLC ("GalvanEyes"), which is the managing partner and 50% owner of the BioCenturion LLC ("BioCenturion") joint venture with Eyelock LLC ("EyeLock"), a subsidiary of VOXX (see Note 11, "Acquisitions"). BioCenturion specializes in creating and deploying authentication solutions to help clients secure their worlds, optimize their workload, and organize their data through customized biometric solutions.

In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR

P/E11.1

Market value$5.49B

1 year-26%

5 years-28%

Charts

As reported to the SEC, without any scoring.

Gentex Corporation (GNTX) reported revenue of $651M in Q2 2026 (quarter ended Jun 30, 2026), down 1.0% from the same quarter a year earlier. That came with a gross margin of 37% and net income of $115M (18% of revenue). For the full year FY2025, revenue was $2.53B (+9.6% year on year) and net income $385M. Its largest product in Q2 2026 was Automotive Mirrors Electronics at $532M, 78% of the disclosed total, well ahead of Premium Speaker Products at 5.5%. The next results filing is expected around Oct 23, 2026, the same week as a year ago.